Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Hindrik Mulder

Hindrik Mulder

Principal investigator

Hindrik Mulder

The R6/2 transgenic mouse model of Huntington's disease develops diabetes due to deficient {beta}-cell mass and exocytosis.

Author

  • Maria Björkqvist
  • Malin Fex
  • Erik Renström
  • Nils Wierup
  • Åsa Petersén
  • Joana Gil
  • Karl Bacos
  • Natalija Popovic
  • Jia-Yi Li
  • Frank Sundler
  • Patrik Brundin
  • Hindrik Mulder

Summary, in English

Diabetes frequently develops in Huntington's disease (HD) patients and in transgenic mouse models of HD such as the R6/2 mouse. The underlying mechanisms have not been clarified. Elucidating the pathogenesis of diabetes in HD would improve our understanding of the molecular mechanisms involved in HD neuropathology. With this aim, we examined our colony of R6/2 mice with respect to glucose homeostasis and islet function. At week 12, corresponding to end-stage HD, R6/2 mice were hyperglycemic and hypoinsulinemic and failed to release insulin in an intravenous glucose tolerance test. In vitro, basal and glucose-stimulated insulin secretion was markedly reduced. Islet nuclear huntingtin inclusions increased dramatically over time, predominantly in ß-cells. ß-cell mass failed to increase normally with age in R6/2 mice. Hence, at week 12, ß-cell mass and pancreatic insulin content in R6/2 mice were 35±5 and 16±3% of that in wild-type mice, respectively. The normally occurring replicating cells were largely absent in R6/2 islets, while no abnormal cell death could be detected. Single cell patch-clamp experiments revealed unaltered electrical activity in R6/2 ß-cells. However, exocytosis was virtually abolished in ß- but not in {alpha}-cells. The blunting of exocytosis could be attributed to a 96% reduction in the number of insulin-containing secretory vesicles. Thus, diabetes in R6/2 mice is caused by a combination of deficient ß-cell mass and disrupted exocytosis.

Department/s

  • Translational Neuroendocrinology
  • Department of Experimental Medical Science
  • Diabetes and Celiac Unit
  • Diabetes - Islet Patophysiology
  • Diabetes - Molecular Metabolism
  • Basal Ganglia Pathophysiology
  • Neural Plasticity and Repair

Publishing year

2005

Language

English

Pages

565-574

Publication/Series

Human Molecular Genetics

Volume

14

Issue

5

Document type

Journal article

Publisher

Oxford University Press

Topic

  • Medical Genetics

Status

Published

Research group

  • Translational Neuroendocrinology
  • Diabetes and Celiac Unit
  • Diabetes - Islet Patophysiology
  • Diabetes - Molecular Metabolism
  • Basal Ganglia Pathophysiology
  • Neural Plasticity and Repair

ISBN/ISSN/Other

  • ISSN: 0964-6906